article · Recent Patents on Anti-Cancer Drug Discovery
The abstract on record is too brief for a reliable plain-language summary, so none has been generated.
Simultaneous targeting of hypoxia and glycolysis pathways by a combination of MEN and OX could be a promising therapy for inhibiting colon cancer cell growth and promoting antitumor immunity [1].
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.2174/1574892818666230116142606
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
